INVO Fertility, Inc. Deferred Compensation Arrangement with Individual, Compensation Expense
INVO Fertility, Inc. (IVF) reported Deferred Compensation Arrangement with Individual, Compensation Expense of $315.89 thousand for the 12-month period ending 2023-12-31, per its 10-K/A filed 2024-11-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DeferredCompensationArrangementWithIndividualCompensationExpense · last filed 2024-11-19
- INVO Fertility, Inc. deferred compensation arrangement with individual, compensation expense for fiscal 2023 was $315.89K.
| Period end | Deferred Compensation Arrangement with Individual, Compensation Expense 12 month |
|---|---|
| 2023-12-31 | $315.89K 10-K/A · filed 2024-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |